Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +0.25% | -2.32% | -7.62% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.62% | 193M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- PBYI Stock
- News Puma Biotechnology, Inc.
- HC Wainwright Lowers Price Target on Puma Biotechnology Inc to $8 From $12, Reiterates Buy Rating